These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6599420)

  • 21. Effect of the anticholinergic drug with calcium antagonistic activity, (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate, on lower urinary tract function in decerebrated dogs.
    Kimura Y; Fukui H; Hamada K; Ogasawara T; Yamazaki C; Ukai Y; Yoshikuni Y; Kimura K
    Arzneimittelforschung; 1997 Feb; 47(2):182-9. PubMed ID: 9079238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical effect of terodiline hydrochloride (TD-758) in patients with urinary disturbances].
    Nakano M; Tajima A; Aso Y; Suzuki K; Hata M; Tsukada T; Masuda H; Hirose J; Kitagawa M; Nakahara M
    Hinyokika Kiyo; 1988 Jan; 34(1):196-200. PubMed ID: 3376801
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of terodiline on patients with detrusor instability.
    Macfarlane JR; Tolley DA
    Scand J Urol Nephrol Suppl; 1984; 87():51-4. PubMed ID: 6399954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A symptomatic and cystometric comparison of terodiline with emepronium in the treatment of women with frequency, urgency and incontinence.
    Sole GM; Arkell DG
    Scand J Urol Nephrol Suppl; 1984; 87():55-7. PubMed ID: 6399955
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomized double-blind trial of terodiline in the treatment of urge incontinence in women.
    Norton P; Karram M; Wall LL; Rosenzweig B; Benson JT; Fantl JA
    Obstet Gynecol; 1994 Sep; 84(3):386-91. PubMed ID: 8058236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibitory effects of NS-21, a novel drug for urinary incontinence, and its active metabolite, RCC-36, on L-type calcium currents in isolated guinea pig detrusor smooth muscle cells.
    Hayashi S; Natsukawa T; Ukai Y; Yoshikuni Y; Kimura K
    Naunyn Schmiedebergs Arch Pharmacol; 1997 May; 355(5):659-66. PubMed ID: 9151307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bladder training and terodiline in females with idiopathic urge incontinence and stable detrusor function.
    Klarskov P; Gerstenberg TC; Hald T
    Scand J Urol Nephrol; 1986; 20(1):41-6. PubMed ID: 3704568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bladder reservoir function in children with monosymptomatic nocturnal enuresis and healthy controls.
    Hagstroem S; Kamperis K; Rittig S; Djurhuus JC
    J Urol; 2006 Aug; 176(2):759-63. PubMed ID: 16813939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urinary bladder innervation in children.
    Kullendorff CM; Elmér M; Alm P
    J Pediatr Surg; 1987 Mar; 22(3):240-2. PubMed ID: 3559868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Enuresis: the viewpoint of the urologist].
    Averous M
    Rev Prat; 1989 Jan; 39(1):15-20. PubMed ID: 2919263
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urodynamic effects of intravesical instillation of terodiline in healthy volunteers and in patients with detrusor hyperactivity.
    Ekström B; Andersson KE; Mattiasson A
    J Urol; 1992 Dec; 148(6):1840-3; discussion 1843-4. PubMed ID: 1433617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of terodiline on hyperreflexia (in vivo) and the in vitro response of isolated strips of rabbit bladder to field stimulation, bethanechol and KCL.
    Levin RM; Scheiner S; Zhao Y; Wein AJ
    Pharmacology; 1993 Jun; 46(6):346-52. PubMed ID: 8100077
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Terodiline: a new compound for the treatment of urge incontinence.
    Wroblewski J
    Ostomy Wound Manage; 1990; 30():22-9. PubMed ID: 2080974
    [No Abstract]   [Full Text] [Related]  

  • 34. A calcium blocking and anticholinergic agent (terodiline) in the treatment of detrusor hyperreflexia: a placebo-controlled, cross-over trial.
    Petersen T; Jakobsen J
    J Neurol Neurosurg Psychiatry; 1987 Oct; 50(10):1331-6. PubMed ID: 3681312
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Terodiline in the treatment of women with urgency and motor urge incontinence. A clinical and urodynamic double-blind cross-over study.
    Gerstenberg TC; Klarskov P; Ramirez D; Hald T
    Br J Urol; 1986 Apr; 58(2):129-33. PubMed ID: 3516296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Maximal electrical stimulation in children with unstable bladder and nocturnal enuresis and/or daytime incontinence: a controlled study.
    Trsinar B; Kraij B
    Neurourol Urodyn; 1996; 15(2):133-42. PubMed ID: 8713559
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characteristics of a tertiary center enuresis population, with special emphasis on the relation among nocturnal diuresis, functional bladder capacity and desmopressin response.
    Dehoorne JL; Walle CV; Vansintjan P; Raes AM; De Guchtenaere AR; Van Laecke E; Hoebeke P; Vande Walle JG
    J Urol; 2007 Mar; 177(3):1130-7. PubMed ID: 17296432
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The system of management nocturnal enuresis based on functional classification].
    Kroll P; Zachwieja J
    Przegl Lek; 2006; 63 Suppl 3():229-32. PubMed ID: 16898539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Oxybutinin-desmopressin association in the treatment of primary nocturnal enuresis with diurnal urination disorders].
    De Grazia E; Cimador M
    Minerva Pediatr; 1999 May; 51(5):149-52. PubMed ID: 10479880
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Routine urodynamic studies is not indicated in children with enuresis].
    Scholtmeijer RJ; Nijman JM
    Ned Tijdschr Geneeskd; 1993 Apr; 137(16):808-10. PubMed ID: 8487883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.